Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak

We developed a chemiluminescence immunoassay method based on the recombinant nucleocapsid antigen and assessed its performance for the clinical diagnosis of severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infections by detecting SARS-CoV-2–specific IgM and IgG antibodies in patients. Full...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Dachuan, Liu, Lei, Zhang, Mingxia, Hu, Yunlong, Yang, Qianting, Guo, Jiubiao, Dai, Youchao, Xu, Yuzhong, Cai, Yi, Chen, Xinchun, Huang, Kaisong, Zhang, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367508/
https://www.ncbi.nlm.nih.gov/pubmed/32681308
http://dx.doi.org/10.1007/s10096-020-03978-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367508/
https://www.ncbi.nlm.nih.gov/pubmed/32681308
http://dx.doi.org/10.1007/s10096-020-03978-6

Ejemplares similares